Monoclonal antibody against CGRP (TEV-48125) for preventive treatment of episodic cluster headache: a phase II randomized clinical trial protocol. (2018). Principles and Practice of Clinical Research, 4(1), 14-20. https://journal.ppcr.org/index.php/ppcrjournal/article/view/53